Downtime in pharmaceutical manufacturing, particularly in oral solid dosage (OSD) production, has a direct impact on throughput, cost efficiency, and supply reliability.
While modern facilities are highly engineered and automated, powder handling between process steps remains a key area where inefficiencies can arise.
How can you reduce downtime while maintaining consistent product quality and well-controlled operations?
In many cases, the answer lies in how materials move through the process, rather than the performance of individual pieces of equipment.
What Causes Downtime in Pharmaceutical Manufacturing?
In today’s pharmaceutical environments, downtime is rarely caused by outdated equipment. Instead, it is driven by process design, material behaviour, and operational constraints.
Common contributors to downtime include:
- Cleaning and changeover strategy
- Cleaning requirements between batches are essential but time-intensive
- Poorly coordinated changeovers can create unnecessary process interruptions
- Powder segregation
- Differences in particle size, density, or flow properties can lead to separation during handling
- This can affect blend uniformity and result in batch variability
- Dust generation and housekeeping
- Powder transfer points can create dust if not well controlled
- Leads to increased cleaning demands and potential cross-contact risk
- Manual intervention
- Additional handling steps increase reliance on operators
- Introduces variability and can slow process flow
- Interdependent process steps
- When process stages are tightly linked, delays in one step can impact overall production flow
- This limits flexibility in scheduling and operations
Why Manufacturing Process Design Matters
In OSD manufacturing, powder handling plays a central role in ensuring:
- Batch-to-batch consistency
- Efficient changeovers
- Process repeatability
- Clean and controlled production environments
Even in highly controlled facilities, the way powders are stored, transferred, and discharged can significantly influence overall performance.
Where Inefficiencies Still Exist in Pharmaceutical Manufacturing
Despite advances in pharmaceutical processing, some inefficiencies remain embedded in how processes are configured:
- Cleaning activities can interrupt production flow if not decoupled
- Multiple transfer steps can increase handling complexity
- Inline dependencies can reduce operational flexibility
- Inconsistent discharge behaviour can affect downstream performance
These challenges are not about outdated systems, but about how processes are structured and connected.
Decoupled IBC-Based Processing Reduces Downtime in Pharmaceutical Manufacturing
Intermediate Bulk Container (IBC) systems, such as those used in Matcon solutions, support a decoupled approach to powder handling.
Instead of tying each process step directly to the next, IBC systems enable stages to operate more independently, allowing better coordination between processing, cleaning, and production scheduling.
Materials can be stored, moved, and discharged in a controlled and repeatable way, helping maintain batch integrity throughout the process.
Key Benefits of IBC-Based Powder Handling
- Reduced downtime through process decoupling
- Cleaning activities can be carried out separately from active production
- Containers can be managed independently of processing equipment
- Reduces the impact of changeovers on overall throughput
- Improved containment and cleanliness
- Enclosed handling helps limit dust release during transfer
- Supports cleaner production environments
- Helps reduce housekeeping requirements between batches
- Consistent batch quality
- Mass-flow discharge allows powders to move uniformly
- Minimises the risk of segregation during discharge
- Maintains blend consistency into downstream processes
- Greater process flexibility
- Decoupled stages allow parallel operations where required
- Reduces bottlenecks between unit operations
- Enables more efficient production planning
- Reduced reliance on manual handling
- Integrated handling reduces the number of intervention points
- Supports more consistent and repeatable operations
- Improved process control
- Controlled discharge supports steady, predictable feed
- Helps stabilise downstream processing
- Supports validation and documentation requirements
Optimising OSD Manufacturing Workflows
Effective powder handling supports every stage of oral solid dosage (OSD) production, from blending through to final processing.
By improving how materials move between stages, manufacturers can:
- Maintain consistent blends throughout production
- Reduce interruptions caused by process dependencies
- Improve overall cleanliness and operational efficiency
- Increase Overall Equipment Effectiveness (OEE)
What This Means for Pharmaceutical Manufacturers
By addressing process-level inefficiencies, pharmaceutical manufacturers can achieve:
- Increased production uptime
- More predictable changeovers
- Improved batch consistency
- Cleaner, more controlled operations
- Greater scheduling flexibility
Reducing downtime is not about replacing equipment; it’s about optimising how the process is designed and connected.
Best Practices for Efficient Powder Handling
When reviewing your process, consider:
- Using mass-flow discharge systems to maintain blend uniformity
- Improving containment during transfer to reduce dust and cleaning effort
- Decoupling cleaning activities from production wherever possible
- Reducing manual handling to support process consistency
In pharmaceutical OSD manufacturing, downtime is often driven by how processes are structured rather than the technology itself.
By adopting decoupled, IBC-based powder handling systems, manufacturers can improve efficiency, maintain consistent product quality, and support well-controlled production environments.
If you are reviewing your powder handling process, explore how Matcon IBC systems can support more efficient, flexible, and reliable pharmaceutical manufacturing operations.
Related reading:
Posted by
Matt Baumber